Global Diagnostic Radiopharmaceuticals Competitive Landscape Professional Research Report 2024
Research Summary
Diagnostic radiopharmaceuticals are specialized compounds containing a radioactive material and a pharmaceutical component that are used in nuclear medicine imaging procedures. These radiopharmaceuticals emit gamma rays, which can be detected by medical imaging devices like gamma cameras or positron emission tomography (PET) scanners. When introduced into the body, these compounds selectively accumulate in specific organs or tissues, allowing healthcare professionals to visualize physiological processes, metabolic activity, or functional abnormalities. Diagnostic radiopharmaceuticals play a crucial role in various medical imaging tests, such as bone scans, cardiac perfusion studies, and PET scans, providing valuable insights into the inner workings of the body and aiding in the diagnosis and monitoring of diseases and conditions.
According to DIResearch's in-depth investigation and research, the global Diagnostic Radiopharmaceuticals market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Diagnostic Radiopharmaceuticals include Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, SIEMENS, Advanced Accelerator Applications, China Isotope & Radiation, Dongcheng Pharmaceutical Group, Lantheus, Eli Lilly etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Diagnostic Radiopharmaceuticals. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Diagnostic Radiopharmaceuticals market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Diagnostic Radiopharmaceuticals market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Diagnostic Radiopharmaceuticals industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Diagnostic Radiopharmaceuticals Include:
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
SIEMENS
Advanced Accelerator Applications
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Diagnostic Radiopharmaceuticals Product Segment Include:
Technetium 99
Fluorine 18
Other
Diagnostic Radiopharmaceuticals Product Application Include:
Oncology
Cardiology
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Diagnostic Radiopharmaceuticals Industry PESTEL Analysis
Chapter 3: Global Diagnostic Radiopharmaceuticals Industry Porter’s Five Forces Analysis
Chapter 4: Global Diagnostic Radiopharmaceuticals Major Regional Market Size and Forecast Analysis
Chapter 5: Global Diagnostic Radiopharmaceuticals Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Diagnostic Radiopharmaceuticals Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Diagnostic Radiopharmaceuticals Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Diagnostic Radiopharmaceuticals Product by Type
- 1.2.1 Global Diagnostic Radiopharmaceuticals Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Technetium 99
- 1.2.3 Fluorine 18
- 1.2.4 Other
- 1.3 Diagnostic Radiopharmaceuticals Product by Application
- 1.3.1 Global Diagnostic Radiopharmaceuticals Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Oncology
- 1.3.3 Cardiology
- 1.3.4 Other
- 1.4 Global Diagnostic Radiopharmaceuticals Market Revenue Analysis (2019-2030)
- 1.5 Diagnostic Radiopharmaceuticals Market Development Status and Trends
- 1.5.1 Diagnostic Radiopharmaceuticals Industry Development Status Analysis
- 1.5.2 Diagnostic Radiopharmaceuticals Industry Development Trends Analysis
- 2 Diagnostic Radiopharmaceuticals Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Diagnostic Radiopharmaceuticals Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Diagnostic Radiopharmaceuticals Market Analysis by Regions
- 4.1 Diagnostic Radiopharmaceuticals Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Diagnostic Radiopharmaceuticals Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2025-2030)
- 5 Global Diagnostic Radiopharmaceuticals Market Size by Type and Application
- 5.1 Global Diagnostic Radiopharmaceuticals Market Size by Type
- 5.2 Global Diagnostic Radiopharmaceuticals Market Size by Application
- 6 North America
- 6.1 North America Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Diagnostic Radiopharmaceuticals Market Size by Type
- 6.4 North America Diagnostic Radiopharmaceuticals Market Size by Application
- 6.5 North America Diagnostic Radiopharmaceuticals Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Diagnostic Radiopharmaceuticals Market Size by Type
- 7.4 Europe Diagnostic Radiopharmaceuticals Market Size by Application
- 7.5 Europe Diagnostic Radiopharmaceuticals Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Diagnostic Radiopharmaceuticals Market Size by Type
- 8.4 China Diagnostic Radiopharmaceuticals Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Diagnostic Radiopharmaceuticals Market Size by Type
- 9.4 APAC (excl. China) Diagnostic Radiopharmaceuticals Market Size by Application
- 9.5 APAC (excl. China) Diagnostic Radiopharmaceuticals Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Diagnostic Radiopharmaceuticals Market Size by Type
- 10.4 Latin America Diagnostic Radiopharmaceuticals Market Size by Application
- 10.5 Latin America Diagnostic Radiopharmaceuticals Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size by Type
- 11.4 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size by Application
- 11.5 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Diagnostic Radiopharmaceuticals Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Diagnostic Radiopharmaceuticals Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Diagnostic Radiopharmaceuticals Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Cardinal Health
- 13.1.1 Cardinal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
- 13.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 GE Healthcare
- 13.2.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
- 13.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Curium Pharma
- 13.3.1 Curium Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
- 13.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Jubilant Pharma
- 13.4.1 Jubilant Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
- 13.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Bracco Imaging
- 13.5.1 Bracco Imaging Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
- 13.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 SIEMENS
- 13.6.1 SIEMENS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
- 13.6.3 SIEMENS Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Advanced Accelerator Applications
- 13.7.1 Advanced Accelerator Applications Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
- 13.7.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 China Isotope & Radiation
- 13.8.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
- 13.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 Dongcheng Pharmaceutical Group
- 13.9.1 Dongcheng Pharmaceutical Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
- 13.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 Lantheus
- 13.10.1 Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
- 13.10.3 Lantheus Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Eli Lilly
- 13.11.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
- 13.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
- 14.2 Diagnostic Radiopharmaceuticals Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Diagnostic Radiopharmaceuticals Typical Downstream Customers
- 14.4 Diagnostic Radiopharmaceuticals Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook